Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AERI - Aerie Pharmaceuticals Inc

Close
15.25
0.010   0.066%

Share volume: 0
Last Updated: Fri 18 Nov 2022 10:00:01 PM CET
Biological Product (except Diagnostic) Manufacturing : -3.41%

PREVIOUS CLOSE
CHG
CHG%
$15.24
0.01
0.07%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022
Report Date 2022-05-06 2022-08-05 2022-11-04
Total revenue 29.835 M 33.311 M 36.129 M
Cost of revenue 6.780 M 3.741 M 6.929 M
Gross profit 23.055 M 29.570 M 29.200 M
    28.26% -1.25%  
Operating expenses 56.698 M 47.707 M 55.872 M
Selling general and admin 31.524 M 28.149 M 33.878 M
Research and development 25.174 M 19.558 M 21.994 M
Total expenses 63.478 M 51.448 M 62.801 M
    -18.95% 22.07%  
Operating income -33.643 M -18.137 M -26.672 M
Ebit -33.643 M -18.137 M -26.672 M
Pretax income -35.198 M -19.323 M -26.731 M
    -45.10% 38.34%  
Income tax 693.000 K 48.000 K 95.000 K
Net income basic -35.891 M -19.371 M -26.826 M
    46.03% -38.49%  
Net income -35.891 M -19.371 M -26.826 M
    46.03% -38.49%